Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (1F32MH115550, MH057440-11)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Received: 29 March 2022
Revised: 17 June 2022
Accepted: 11 July 2022
First Online: 23 July 2022
: AAG received funds from the following organizations: Lundbeck, Pfizer, Otsuka, Asubio, Autofony, Janssen, Alkermes, SynAgile, and Newron. DMB, CMF, and CCP declare no competing financial interests.